These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 21067337
1. Study of the influence of alkalizing components on matrix pellets prepared by extrusion/spheronization. Hamedelniel EI, Bajdik J, Kása P, Pintye-Hódi K. Pharm Dev Technol; 2012; 17(2):204-11. PubMed ID: 21067337 [Abstract] [Full Text] [Related]
2. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets. Maboos M, Yousuf RI, Shoaib MH, Nasiri I, Hussain T, Ahmed HF, Iffat W. Lipids Health Dis; 2018 Jun 09; 17(1):136. PubMed ID: 29885655 [Abstract] [Full Text] [Related]
3. Differences in characteristics of pellets prepared by different pelletization methods. Häring A, Vetchý D, Janovská L, Krejcová K, Rabisková M. Drug Dev Ind Pharm; 2008 Mar 09; 34(3):289-96. PubMed ID: 18363144 [Abstract] [Full Text] [Related]
4. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets. Wei H, Qing D, De-Ying C, Bai X, Fanli-Fang. PDA J Pharm Sci Technol; 2007 Mar 09; 61(2):121-30. PubMed ID: 17479720 [Abstract] [Full Text] [Related]
6. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization. Goyanes A, Martínez-Pacheco R. Drug Dev Ind Pharm; 2015 Mar 09; 41(3):362-8. PubMed ID: 24279425 [Abstract] [Full Text] [Related]
7. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C. Eur J Pharm Biopharm; 2008 Sep 09; 70(1):302-12. PubMed ID: 18579353 [Abstract] [Full Text] [Related]
8. Development and evaluation of omeprazole pellets fabricated by sieving-spheronization and extrusion - spheronization process. Karim S, Baie SH, Hay YK, Bukhari NI. Pak J Pharm Sci; 2014 May 09; 27(3):425-38. PubMed ID: 24811797 [Abstract] [Full Text] [Related]
10. Formulation development and optimization: Encapsulated system of Atenolol and Glyburide. Maboos M, Yousuf RI, Shoaib MH. Pak J Pharm Sci; 2016 Mar 09; 29(2):569-77. PubMed ID: 27087100 [Abstract] [Full Text] [Related]
13. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization. Sinha VR, Agrawal MK, Kumria R. Curr Drug Deliv; 2005 Jan 09; 2(1):1-8. PubMed ID: 16305403 [Abstract] [Full Text] [Related]
14. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. Serratoni M, Newton M, Booth S, Clarke A. Eur J Pharm Biopharm; 2007 Jan 09; 65(1):94-8. PubMed ID: 17056237 [Abstract] [Full Text] [Related]
15. Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs. Chopra S, Venkatesan N, Betageri GV. Int J Pharm; 2013 Mar 25; 446(1-2):136-44. PubMed ID: 23422274 [Abstract] [Full Text] [Related]
16. The evaluation of formulations for the preparation of new formula pellets. Gajdziok J, Bernatoniene J, Muselík J, Masteiková R, Dvořáčková K, Petkeviciute Z, Lazauskas R, Kalveniene Z, Bernatoniene R. Pharm Dev Technol; 2011 Oct 25; 16(5):520-8. PubMed ID: 20649408 [Abstract] [Full Text] [Related]
19. Alginate-based pellets prepared by extrusion/spheronization: a preliminary study on the effect of additive in granulating liquid. Sriamornsak P, Nunthanid J, Luangtana-anan M, Puttipipatkhachorn S. Eur J Pharm Biopharm; 2007 Aug 25; 67(1):227-35. PubMed ID: 17276664 [Abstract] [Full Text] [Related]